Characteristic | Breast cancer death/death | Unadjusted SHR* | Adjusted SHR† |
TNM stage | |||
I | 209/720 | 1.00 | 1.00 |
II | 680/1186 | 3.99 (3.42 to 4.65) | 3.87 (3.32 to 4.53) |
II | 460/582 | 10.69 (9.09 to 12.57) | 10.87 (9.22 to 12.81) |
IV | 391/436 | 45.82 (38.15 to 55.03) | 41.97 (34.78 to 50.65) |
Age at diagnosis (years) | |||
<50 | 365/405 | 1.00 | 1.00 |
50–59 | 404/526 | 0.83 (0.77 to 1.02) | 1.10 (0.95 to 1.27) |
60–69 | 342/556 | 0.78 (0.68 to 0.90) | 1.05 (0.91 to 1.22) |
70–79 | 329/699 | 1.31 (1.13 to 1.52) | 1.43 (1.22 to 1.67) |
80+ | 300/738 | 2.22 (1.89 to 2.59) | 2.24 (1.90 to 2.66) |
Country of birth | |||
Australia | 1049/1777 | 1.00 | 1.00 |
Other English-speaking countries | 247/412 | 0.98 (0.85 to 1.12) | 1.01 (0.87 to 1.17) |
Non-English-speaking countries | 200/346 | 1.02 (0.87 to 1.18) | 0.98 (0.84 to 1.15) |
Unknown | 244/389 | 1.08 (0.94 to 1.25) | 1.15 (1.00 to 1.33) |
Diagnostic period | |||
2000–2004 | 884/1512 | 1.00 | 1.00 |
2005–2009 | 654/1076 | 0.81 (0.73 to 0.90) | 0.75 (0.67 to 0.83) |
2010–2014 | 202/336 | 0.62 (0.53 to 0.72) | 0.57 (0.48 to 0.67) |
Residential remoteness | |||
Major city | 1302/2186 | 1.00 | 1.00 |
Inner regional | 185/313 | 0.99 (0.85 to 1.16) | 1.01 (0.86 to 1.20) |
Outer regional/remote/very remote | 253/425 | 1.01 (0.88 to 1.15) | 0.97 (0.84 to 1.13) |
SEIFA IRSD quintile | |||
1 (most disadvantaged) | 364/605 | 1.00 | 1.00 |
2 | 371/604 | 0.88 (0.76 to 1.02) | 0.93 (0.79 to 1.09) |
3 | 353/613 | 0.80 (0.69 to 0.93) | 0.85 (0.72 to 0.99) |
4 | 328/544 | 0.79 (0.68 to 0.92) | 0.85 (0.73 to 1.00) |
5 (least disadvantage) | 324/558 | 0.67 (0.58 to 0.78) | 0.73 (0.62 to 0.87) |
*Unadjusted SHRs derived from univariate competing risk regression modelling, deaths followed to 31 December 2014.
†Adjusted SHRs derived from multivariate competing risk regression model adjusting by including cancer stage, age, country of birth, diagnosis period, residential remoteness and Socioeconomic Index for Areas (SEIFA) quintile.
IRSD, Index of Relative Socioeconomic Disadvantage.